| scholarly article | Q13442814 |
| P50 | author | Stefan W. Krause | Q56915515 |
| P2093 | author name string | Christoph Ammon | |
| Michael Rehli | |||
| Reinhard Andreesen | |||
| Hans-Helmut Niller | |||
| Lucia Schwarzfischer | |||
| Sabine Langmann | |||
| P2860 | cites work | Chitotriosidase, a chitinase, and the 39-kDa human cartilage glycoprotein, a chitin-binding lectin, are homologues of family 18 glycosyl hydrolases secreted by human macrophages | Q24315996 |
| The chitinase 3-like protein human cartilage glycoprotein 39 (HC-gp39) stimulates proliferation of human connective-tissue cells and activates both extracellular signal-regulated kinase- and protein kinase B-mediated signalling pathways | Q24534189 | ||
| 57 Sequencing end-labeled DNA with base-specific chemical cleavages | Q27860479 | ||
| Cloning of a cDNA encoding chitotriosidase, a human chitinase produced by macrophages | Q28114942 | ||
| PU.1 and interferon consensus sequence-binding protein regulate the myeloid expression of the human Toll-like receptor 4 gene | Q28139719 | ||
| Molecular characterization of the gene for human cartilage gp-39 (CHI3L1), a member of the chitinase protein family and marker for late stages of macrophage differentiation | Q28245478 | ||
| Orchestrated response: a symphony of transcription factors for gene control | Q28679048 | ||
| In vivo footprinting of a muscle specific enhancer by ligation mediated PCR. | Q34550385 | ||
| Transcriptional regulation of granulocyte and monocyte development | Q34658545 | ||
| CD18 (beta 2 leukocyte integrin) promoter requires PU.1 transcription factor for myeloid activity | Q34734315 | ||
| Antagonism between C/EBPbeta and FOG in eosinophil lineage commitment of multipotent hematopoietic progenitors | Q35204890 | ||
| Raised human cartilage glycoprotein-39 plasma levels in patients with rheumatoid arthritis and other inflammatory conditions | Q35549462 | ||
| Restriction of interferon gamma responsiveness and basal expression of the myeloid human Fc gamma R1b gene is mediated by a functional PU.1 site and a transcription initiator consensus | Q36363233 | ||
| Serum YKL-40 and colorectal cancer. | Q36619099 | ||
| Cell-specific expression of the macrophage scavenger receptor gene is dependent on PU.1 and a composite AP-1/ets motif | Q36656291 | ||
| Effects of different DNA polymerases in ligation-mediated PCR: enhanced genomic sequencing and in vivo footprinting | Q36815765 | ||
| c-Jun is a JNK-independent coactivator of the PU.1 transcription factor. | Q38328224 | ||
| Sp1 and Sp3 are involved in up-regulation of human deoxyribonuclease II transcription during differentiation of HL-60 cells. | Q38355603 | ||
| The t(8;21) fusion product, AML-1-ETO, associates with C/EBP-alpha, inhibits C/EBP-alpha-dependent transcription, and blocks granulocytic differentiation | Q39631307 | ||
| The myeloid-cell-specific c-fes promoter is regulated by Sp1, PU.1, and a novel transcription factor | Q40018578 | ||
| Osteopetrosis in mice lacking haematopoietic transcription factor PU.1. | Q41121255 | ||
| Nucleoprotein complexes and DNA 5'-ends at oriP of Epstein-Barr virus | Q41343623 | ||
| A new biochemical marker for joint injury. Analysis of YKL-40 in serum and synovial fluid. | Q41517613 | ||
| Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. | Q52214235 | ||
| Strong induction of members of the chitinase family of proteins in atherosclerosis: chitotriosidase and human cartilage gp-39 expressed in lesion macrophages. | Q54102953 | ||
| The myeloid master regulator transcription factor PU.1 is inactivated by AML1-ETO in t(8;21) myeloid leukemia | Q57615556 | ||
| P433 | issue | 45 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | macrophage | Q184204 |
| P304 | page(s) | 44058-44067 | |
| P577 | publication date | 2003-08-20 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Transcriptional regulation of CHI3L1, a marker gene for late stages of macrophage differentiation | |
| P478 | volume | 278 |
| Q24624033 | A complex of nuclear factor I-X3 and STAT3 regulates astrocyte and glioma migration through the secreted glycoprotein YKL-40 |
| Q44505138 | A novel 43-kDa protein as a negative regulatory component of phenoloxidase-induced melanin synthesis |
| Q98204288 | Association of glial and neuronal degeneration markers with Alzheimer's disease cerebrospinal fluid profile and cognitive functions |
| Q36568996 | Astrocyte and macrophage regulation of YKL-40 expression and cellular response in neuroinflammation |
| Q47855094 | Atherosclerosis is exacerbated by chitinase-3-like-1 in amyloid precursor protein transgenic mice |
| Q38341537 | Building promoter aware transcriptional regulatory networks using siRNA perturbation and deepCAGE. |
| Q40410464 | CHI3L1 overexpression is associated with metastasis and is an indicator of poor prognosis in papillary thyroid carcinoma |
| Q47325932 | Chitinase 3-like 1 secreted by peritumoral macrophages in esophageal squamous cell carcinoma is a favorable prognostic factor for survival |
| Q33576348 | Chitinase 3-like 1 synergistically activates IL6-mediated STAT3 phosphorylation in intestinal epithelial cells in murine models of infectious colitis |
| Q34654335 | Chitinase family GH18: evolutionary insights from the genomic history of a diverse protein family |
| Q99417962 | Chitinase-3 like-protein-1 function and its role in diseases |
| Q53067238 | Chitinase-3-like protein 1 protects skeletal muscle from TNFα-induced inflammation and insulin resistance. |
| Q35984042 | Chitinase-like proteins in lung injury, repair, and metastasis |
| Q38909229 | Chitosan leads to downregulation of YKL-40 and inflammasome activation in human macrophages |
| Q54488554 | Circulating YKL-40 levels during human endotoxaemia. |
| Q37675836 | Correlation of Chitinase 3-Like 1 Single Nucleotide Polymorphisms with Hepatocellular Carcinoma in Taiwan |
| Q38915171 | Diagnostic function of the neuroinflammatory biomarker YKL-40 in Alzheimer's disease and other neurodegenerative diseases |
| Q44510075 | Elevated serum YKL-40 level predicts myocardial reperfusion and in-hospital MACE in patients with STEMI. |
| Q61465196 | Evaluation of CHI3L-1 and CHIT-1 Expression in Differentiated and Polarized Macrophages |
| Q93335290 | Evaluation of the antifibrotic potency by knocking down SPARC, CCR2 and SMAD3 |
| Q37413102 | Exploring the role of CHI3L1 in "pre-metastatic" lungs of mammary tumor-bearing mice. |
| Q40242687 | Extracellular matrix markers and risk of myocardial infarction: The HUNT Study in Norway |
| Q89657326 | Functional lncRNA-miRNA-mRNA networks in rabbit carotid atherosclerosis |
| Q45870247 | Gene delivery by the hSP-B promoter to lung alveolar type II epithelial cells in LAL-knockout mice through bone marrow mesenchymal stem cells |
| Q33647944 | Gene expression profiling in the lung tissue of cynomolgus monkeys in response to repeated exposure to welding fumes |
| Q51778180 | High serum YKL-40 concentration is associated with cardiovascular and all-cause mortality in patients with stable coronary artery disease. |
| Q43242537 | How to target small cell lung cancer |
| Q37280948 | Human chitinases and chitinase-like proteins as indicators for inflammation and cancer |
| Q24299238 | IL-6, but not TNF-α, increases plasma YKL-40 in human subjects |
| Q55279699 | Immunomodulation of Host Chitinase 3-Like 1 During a Mammary Pathogenic Escherichia coli Infection. |
| Q37370893 | Increased immunohistochemical expression of YKL-40 in the spleen of patients with portal hypertension |
| Q24338555 | Inflammatory cytokines induce production of CHI3L1 by articular chondrocytes |
| Q36709555 | Is YKL-40 a new therapeutic target in cancer? |
| Q36402008 | Neurogranin and YKL-40: independent markers of synaptic degeneration and neuroinflammation in Alzheimer's disease |
| Q38903303 | New Insights Into the Relationship Between Chitinase-3-Like-1 and Asthma |
| Q33804552 | Non-coding RNA Contribution to Thoracic and Abdominal Aortic Aneurysm Disease Development and Progression |
| Q89125430 | Non-coding RNAs in aneurysmal aortopathy |
| Q37605869 | Plasma YKL-40: a potential new cancer biomarker? |
| Q37298658 | Potential biomarkers of insulin resistance and atherosclerosis in type 2 diabetes mellitus patients with coronary artery disease. |
| Q24656942 | Potential role of chitinase 3-like-1 in inflammation-associated carcinogenic changes of epithelial cells |
| Q35557987 | Promoter polymorphisms in the chitinase 3-like 1 gene influence the serum concentration of YKL-40 in Danish patients with rheumatoid arthritis and in healthy subjects |
| Q36424863 | Regulation of YKL-40 expression by corticosteroids: effect on pro-inflammatory macrophages in vitro and its modulation in COPD in vivo. |
| Q46383598 | Regulation of YKL-40 expression during genotoxic or microenvironmental stress in human glioblastoma cells |
| Q35164695 | RelB/p50 complexes regulate cytokine-induced YKL-40 expression |
| Q33732189 | Resveratrol represses YKL-40 expression in human glioma U87 cells |
| Q48463092 | Role for mammalian chitinase 3-like protein 1 in traumatic brain injury |
| Q35103881 | Role of breast regression protein-39 in the pathogenesis of cigarette smoke-induced inflammation and emphysema |
| Q37807414 | Role of chitin and chitinase/chitinase-like proteins in inflammation, tissue remodeling, and injury. |
| Q38836316 | Role of inflammatory marker YKL-40 in the diagnosis, prognosis and cause of cardiovascular and liver diseases |
| Q39950004 | Selective repression of YKL-40 by NF-kappaB in glioma cell lines involves recruitment of histone deacetylase-1 and -2. |
| Q37218917 | Serum YKL-40 Levels in Patients with Gastric Cancer |
| Q37339883 | Serum YKL-40 as a marker of liver fibrosis in patients with non-alcoholic fatty liver disease |
| Q33255102 | Serum YKL-40 concentrations in newly diagnosed multiple myeloma patients and YKL-40 expression in malignant plasma cells |
| Q80482812 | Serum YKL-40 levels and chitotriosidase activity as potential biomarkers in primary prostate cancer and benign prostatic hyperplasia |
| Q37720473 | Serum YKL-40 levels and chitotriosidase activity in patients with beta-thalassemia major. |
| Q51292057 | Serum YKL-40 levels in gestational diabetes mellitus. |
| Q35153678 | Specific targeting of gene expression to a subset of human trabecular meshwork cells using the chitinase 3-like 1 promoter |
| Q58796710 | Suppression of metastasis through inhibition of chitinase 3-like 1 expression by miR-125a-3p-mediated up-regulation of USF1 |
| Q35745168 | The Inflammatory Marker YKL-40 Is Elevated in Cerebrospinal Fluid from Patients with Alzheimer's but Not Parkinson's Disease or Dementia with Lewy Bodies |
| Q27313397 | The Role of CHI3L1 (Chitinase-3-Like-1) in the Pathogenesis of Infections in Burns in a Mouse Model |
| Q36597948 | The biology of the Gaucher cell: the cradle of human chitinases. |
| Q24292760 | The chitinase-like protein YKL-40 is secreted by airway epithelial cells at base line and in response to compressive mechanical stress |
| Q34269049 | The chitinase-like proteins breast regression protein-39 and YKL-40 regulate hyperoxia-induced acute lung injury. |
| Q45958978 | The diagnostic and prognostic value of serum YKL-40 in endometrial cancer. |
| Q37722600 | The inflammatory biomarker YKL-40 decreases stepwise after exercise stress test |
| Q37762444 | The role of PU.1 and GATA-1 transcription factors during normal and leukemogenic hematopoiesis |
| Q38179983 | The significance of YKL-40 protein in liver fibrosis |
| Q89621107 | YKL-39 as a Potential New Target for Anti-Angiogenic Therapy in Cancer |
| Q41073254 | YKL-40 acts as an angiogenic factor to promote tumor angiogenesis |
| Q36300687 | YKL-40 and genetic status of CHI3L1 in a large group of asthmatics |
| Q42320020 | YKL-40 and its complex association with metabolic syndrome, obesity, and cardiovascular disease |
| Q38759253 | YKL-40 as a Potential Biomarker and a Possible Target in Therapeutic Strategies of Alzheimer's Disease |
| Q34142567 | YKL-40 expression in traumatic brain injury: an initial analysis |
| Q35823055 | YKL-40 genetic polymorphisms and the risk of liver disease progression in patients with advanced fibrosis due to chronic hepatitis C |
| Q37482262 | YKL-40 in allogeneic hematopoietic cell transplantation after AML and myelodysplastic syndrome |
| Q45811351 | YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias. |
| Q39433175 | YKL-40 is differentially expressed in human embryonic stem cells and in cell progeny of the three germ layers |
| Q79624448 | YKL-40 protein expression in normal adult human tissues--an immunohistochemical study |
| Q33343967 | YKL-40, a marker of simian immunodeficiency virus encephalitis, modulates the biological activity of basic fibroblast growth factor |
| Q37636543 | YKL-40--an emerging biomarker in cardiovascular disease and diabetes |
| Q37334247 | YKL-40-A Protein in the Field of Translational Medicine: A Role as a Biomarker in Cancer Patients? |
| Q37779310 | YKL-40: a new biomarker in cardiovascular disease? |
| Q37392423 | YKL-40: a potential biomarker for osteoarthritis |
| Q30596758 | miR-24 limits aortic vascular inflammation and murine abdominal aneurysm development |
Search more.